Thought the increasing Covid hospitalisations would impact sales but the US is progressing well, and they provided sales numbers this time (finally). This also feels like the most transparent update they have given, they mentioned UK/IRE and Europe underperforming in Q2 and explained how they aim to fix this. Some previous announcements mainly focused on the positives but this is a very balanced update.
Also new CEO in the first quarter 2022 is what I want to hear.
Ann: Record US sales in July and Nov, and other matters, page-3
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.05 |
Change
-0.040(1.91%) |
Mkt cap ! $1.414B | |||
| Open | High | Low | Value | Volume |
| $2.10 | $2.14 | $2.04 | $1.879M | 908.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4378 | $2.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.06 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.06 |
Change
-0.040 ( 1.57 %) |
||||
| Open | High | Low | Volume | ||
| $2.11 | $2.14 | $2.04 | 350187 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| PNV (ASX) Chart |